상세 보기
CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
- Han, Gwan Hee;
- Kim, Julie;
- Yun, Hee;
- Cho, Hanbyoul;
- Chung, Joon-Yong;
- 외 2명
WEB OF SCIENCE
18SCOPUS
17초록
Background/Aim: Cryptochrome 1 (CRY1), a core circadian gene, modulates circadian rhythm and carcinogenesis. Here, we investigated the role of CRY1 and its correlation with NANOG, a stem cell transcription factor, in cervical cancer. Materials and Methods: Immunohistochemistry with tissue microarray was performed to evaluate CRY1 and NANOG expression in cervical cancer tissues, and their functional roles were assessed in cervical cancer cell lines. Results: CRY1 or NANOG was significantly over-expressed in cervical cancer tissues. Notably, combined over-expression of CRY1 and NANOG was correlated with a significantly poor OS and DFS and showed a stronger predictive value for chemoradiation response than each single protein. Furthermore, siCRY1 induced apoptosis, decreased NANOG expression, suppressed STAT3 signalling, and activated p53 signalling in cervical cancer cell lines. Conclusion: CRY1 and NANOG over expression serves as a strong predictive biomarker for prognosis and chemoradiation response, and may be a new therapeutic target in patients with cervical cancer.
키워드
- 제목
- CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer
- 저자
- Han, Gwan Hee; Kim, Julie; Yun, Hee; Cho, Hanbyoul; Chung, Joon-Yong; Kim, Jae-Hoon; Hewitt, Stephen M.
- 발행일
- 2021-11
- 유형
- Article
- 권
- 18
- 호
- 6
- 페이지
- 699 ~ 713
- 언어
- ENG
- 출판사
- INT INST ANTICANCER RESEARCH
- 발행국가
- 그리스
- 분량
- 15 페이지
- ISSN
- E 1790-6245
P 1109-6535